Fujirebio is a global in vitro diagnostics (IVD) company with over 50 years of expertise in biomarker innovation, offering CDMO services for diagnostic products. The company provides contract development and manufacturing for diagnostic partners, including reagent development, manufacturing, and clinical and regulatory services. Fujirebio is particularly known for its FDA-cleared Alzheimer's disease blood-based biomarkers on its Lumipulse platform.
IVD CDMO services, biomarker development, diagnostic reagent manufacturing, Lumipulse platform, Alzheimer's diagnostics
3 sites worldwide
No certifications on file yet.
No reviews available yet.
No documents available.